BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Clinical ink - ECPv6.10.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Clinical ink
X-ORIGINAL-URL:https://www.clinicalink.com
X-WR-CALDESC:Events for Clinical ink
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220915
DTEND;VALUE=DATE:20220919
DTSTAMP:20250403T031534
CREATED:20220915T080000Z
LAST-MODIFIED:20231013T210910Z
UID:10725-1663200000-1663545599@www.clinicalink.com
SUMMARY:International Congress of Parkinson’s Disease and Movement Disorders
DESCRIPTION:How can you access larger pools of clinical trial participants? Gain the ability to target specific populations? Address potential ethical considerations? Ensure timely data accuracy? Protect participant privacy? Join Joan Severson\, Chief Innovation Officer at Clinical ink\, Bryan Hansen\, Director of Data Science and Digital Health-Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson\, and Maimah Karmo\, Chief Executive Officer at the Tigerlily Foundation\, at this SXSW panel presented by Real Chemistry. A panel focused on the evolution of innovative data sources for clinical trial recruitment\, discussing online platforms\, real world data\, and social networks: How to maximize their effectiveness and how to identify the right candidates for a study. Understand and evaluate the advantages and disadvantages of different data sources\, from adopting the latest technology to realizing patient diversity and achieving cost savings. Recordings will be released post the live event. Learn more at https://schedule.sxsw.com/2023/events/PP132054 								\n				\n				\n				\n									Innovative Data Approaches to Clinical Trial RecruitmentMarch 12\, 2023 | 1:00pm – 2:00pmAustin Convention Center – Creative Industries Expo – Podcast Lounge – Exhibit Hall 3Joan Severson\, Chief Innovation Officer\, Clinical ink
URL:https://www.clinicalink.com/event/parkinsons-disease-movement-disorders-congress-2022/
LOCATION:Marriott Auditorium Hotel and Coference Centre\, Avda de Aragón\, Madrid\, Spain
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/IPMDS.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220913
DTEND;VALUE=DATE:20220915
DTSTAMP:20250403T031534
CREATED:20220913T080000Z
LAST-MODIFIED:20220930T085018Z
UID:10721-1663027200-1663199999@www.clinicalink.com
SUMMARY:DPHARM Disruptive Innovations to Modernize Clinical Research
DESCRIPTION:How can you access larger pools of clinical trial participants? Gain the ability to target specific populations? Address potential ethical considerations? Ensure timely data accuracy? Protect participant privacy? Join Joan Severson\, Chief Innovation Officer at Clinical ink\, Bryan Hansen\, Director of Data Science and Digital Health-Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson\, and Maimah Karmo\, Chief Executive Officer at the Tigerlily Foundation\, at this SXSW panel presented by Real Chemistry. A panel focused on the evolution of innovative data sources for clinical trial recruitment\, discussing online platforms\, real world data\, and social networks: How to maximize their effectiveness and how to identify the right candidates for a study. Understand and evaluate the advantages and disadvantages of different data sources\, from adopting the latest technology to realizing patient diversity and achieving cost savings. Recordings will be released post the live event. Learn more at https://schedule.sxsw.com/2023/events/PP132054 								\n				\n				\n				\n									Innovative Data Approaches to Clinical Trial RecruitmentMarch 12\, 2023 | 1:00pm – 2:00pmAustin Convention Center – Creative Industries Expo – Podcast Lounge – Exhibit Hall 3Joan Severson\, Chief Innovation Officer\, Clinical ink
URL:https://www.clinicalink.com/event/dpharm-disruptive-innovation-conference-2022/
LOCATION:The Westin\, Copely Place\, Boston\, MA\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/DPHARM.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220912
DTEND;VALUE=DATE:20220913
DTSTAMP:20250403T031534
CREATED:20220912T080000Z
LAST-MODIFIED:20231013T205748Z
UID:10716-1662940800-1663027199@www.clinicalink.com
SUMMARY:Mobile Tech in Clinical Trials
DESCRIPTION:How can you access larger pools of clinical trial participants? Gain the ability to target specific populations? Address potential ethical considerations? Ensure timely data accuracy? Protect participant privacy? Join Joan Severson\, Chief Innovation Officer at Clinical ink\, Bryan Hansen\, Director of Data Science and Digital Health-Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson\, and Maimah Karmo\, Chief Executive Officer at the Tigerlily Foundation\, at this SXSW panel presented by Real Chemistry. A panel focused on the evolution of innovative data sources for clinical trial recruitment\, discussing online platforms\, real world data\, and social networks: How to maximize their effectiveness and how to identify the right candidates for a study. Understand and evaluate the advantages and disadvantages of different data sources\, from adopting the latest technology to realizing patient diversity and achieving cost savings. Recordings will be released post the live event. Learn more at https://schedule.sxsw.com/2023/events/PP132054 								\n				\n				\n				\n									Innovative Data Approaches to Clinical Trial RecruitmentMarch 12\, 2023 | 1:00pm – 2:00pmAustin Convention Center – Creative Industries Expo – Podcast Lounge – Exhibit Hall 3Joan Severson\, Chief Innovation Officer\, Clinical ink
URL:https://www.clinicalink.com/event/mobile-tech-clinical-trials-conference-2022/
LOCATION:The Westin\, Copely Place\, Boston\, MA\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/Mobile-Tech.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220911
DTEND;VALUE=DATE:20220915
DTSTAMP:20250403T031534
CREATED:20220911T000000Z
LAST-MODIFIED:20230327T223258Z
UID:10710-1662854400-1663199999@www.clinicalink.com
SUMMARY:SCDM – Society for Clinical Data Management - Annual Conference 2022
DESCRIPTION:How can you access larger pools of clinical trial participants? Gain the ability to target specific populations? Address potential ethical considerations? Ensure timely data accuracy? Protect participant privacy? Join Joan Severson\, Chief Innovation Officer at Clinical ink\, Bryan Hansen\, Director of Data Science and Digital Health-Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson\, and Maimah Karmo\, Chief Executive Officer at the Tigerlily Foundation\, at this SXSW panel presented by Real Chemistry. A panel focused on the evolution of innovative data sources for clinical trial recruitment\, discussing online platforms\, real world data\, and social networks: How to maximize their effectiveness and how to identify the right candidates for a study. Understand and evaluate the advantages and disadvantages of different data sources\, from adopting the latest technology to realizing patient diversity and achieving cost savings. Recordings will be released post the live event. Learn more at https://schedule.sxsw.com/2023/events/PP132054 								\n				\n				\n				\n									Innovative Data Approaches to Clinical Trial RecruitmentMarch 12\, 2023 | 1:00pm – 2:00pmAustin Convention Center – Creative Industries Expo – Podcast Lounge – Exhibit Hall 3Joan Severson\, Chief Innovation Officer\, Clinical ink
URL:https://www.clinicalink.com/event/scdm-annual-conference-2022/
LOCATION:San Antonio\, TX\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/SCDM-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220907
DTEND;VALUE=DATE:20220910
DTSTAMP:20250403T031534
CREATED:20220907T080000Z
LAST-MODIFIED:20230327T223225Z
UID:10705-1662508800-1662767999@www.clinicalink.com
SUMMARY:PCMG “Harnessing Change\, Expanding Expertise\, Growing Sustainability”
DESCRIPTION:How can you access larger pools of clinical trial participants? Gain the ability to target specific populations? Address potential ethical considerations? Ensure timely data accuracy? Protect participant privacy? Join Joan Severson\, Chief Innovation Officer at Clinical ink\, Bryan Hansen\, Director of Data Science and Digital Health-Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson\, and Maimah Karmo\, Chief Executive Officer at the Tigerlily Foundation\, at this SXSW panel presented by Real Chemistry. A panel focused on the evolution of innovative data sources for clinical trial recruitment\, discussing online platforms\, real world data\, and social networks: How to maximize their effectiveness and how to identify the right candidates for a study. Understand and evaluate the advantages and disadvantages of different data sources\, from adopting the latest technology to realizing patient diversity and achieving cost savings. Recordings will be released post the live event. Learn more at https://schedule.sxsw.com/2023/events/PP132054 								\n				\n				\n				\n									Innovative Data Approaches to Clinical Trial RecruitmentMarch 12\, 2023 | 1:00pm – 2:00pmAustin Convention Center – Creative Industries Expo – Podcast Lounge – Exhibit Hall 3Joan Severson\, Chief Innovation Officer\, Clinical ink
URL:https://www.clinicalink.com/event/pcmg-annual-conference-2022/
LOCATION:Doubletree by Hilton\, Krakow\, Poland
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/PCMG.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220731T080000
DTEND;TZID=UTC:20220804T170000
DTSTAMP:20250403T031534
CREATED:20220731T080000Z
LAST-MODIFIED:20221012T091055Z
UID:10701-1659254400-1659632400@www.clinicalink.com
SUMMARY:AAIC 2022 Alzheimer’s Association
DESCRIPTION:How can you access larger pools of clinical trial participants? Gain the ability to target specific populations? Address potential ethical considerations? Ensure timely data accuracy? Protect participant privacy? Join Joan Severson\, Chief Innovation Officer at Clinical ink\, Bryan Hansen\, Director of Data Science and Digital Health-Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson\, and Maimah Karmo\, Chief Executive Officer at the Tigerlily Foundation\, at this SXSW panel presented by Real Chemistry. A panel focused on the evolution of innovative data sources for clinical trial recruitment\, discussing online platforms\, real world data\, and social networks: How to maximize their effectiveness and how to identify the right candidates for a study. Understand and evaluate the advantages and disadvantages of different data sources\, from adopting the latest technology to realizing patient diversity and achieving cost savings. Recordings will be released post the live event. Learn more at https://schedule.sxsw.com/2023/events/PP132054 								\n				\n				\n				\n									Innovative Data Approaches to Clinical Trial RecruitmentMarch 12\, 2023 | 1:00pm – 2:00pmAustin Convention Center – Creative Industries Expo – Podcast Lounge – Exhibit Hall 3Joan Severson\, Chief Innovation Officer\, Clinical ink
URL:https://www.clinicalink.com/event/alzheimers-association-international-conference-2022/
LOCATION:San Diego Convention Centre\, 111 W Harbor Drive\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/AA.jpg
END:VEVENT
END:VCALENDAR